![PRD_001159 PRD_001159](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001159.svg) | PRD_001159 | Name: | PL-74 | Formula: | C46 H74 N10 O13 P S | Definition date: | 2013-12-11 | Last modified: | 2013-12-11 |
|
![PRD_001130 PRD_001130](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001130.svg) | PRD_001130 | Name: | SmBz, cyclosporin A derivative | Formula: | C70 H118 N11 O14 | Definition date: | 2013-11-06 | Last modified: | 2013-11-06 |
|
![PRD_001187 PRD_001187](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001187.svg) | PRD_001187 | Name: | pGly[807,811], a stapled myoA tail peptide | Formula: | C98 H177 N31 O23 S | Definition date: | 2013-11-06 | Last modified: | 2013-11-06 |
|
![PRD_000777 PRD_000777](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000777.svg) | PRD_000777 | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | Formula: | C41 H69 N9 O9 | Definition date: | 2013-10-30 | Last modified: | 2013-10-30 |
|
![PRD_000778 PRD_000778](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000778.svg) | PRD_000778 | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-3-phenylpropyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | Formula: | C44 H67 N9 O9 | Definition date: | 2013-10-30 | Last modified: | 2013-10-30 |
|
![PRD_002087 PRD_002087](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002087.svg) | PRD_002087 | Formula: | C18 H25 N5 O6 | Definition date: | 2013-10-02 | Last modified: | 2013-10-02 |
|
![PRD_001124 PRD_001124](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001124.svg) | PRD_001124 | Name: | Cyclomarin A | Formula: | C56 H84 N8 O11 | Definition date: | 2013-09-18 | Last modified: | 2013-09-18 |
|
![PRD_001145 PRD_001145](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001145.svg) | PRD_001145 | Name: | BIVALIRUDIN | Formula: | C78 H110 N18 O30 | Definition date: | 2013-09-04 | Last modified: | 2013-09-04 |
|
![PRD_001148 PRD_001148](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001148.svg) | PRD_001148 | Name: | BIVALIRUDIN | Formula: | C20 H31 N6 O4 | Definition date: | 2013-09-04 | Last modified: | 2013-09-04 |
|
![PRD_000874 PRD_000874](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000874.svg) | PRD_000874 | Name: | PawS Derived Peptide 4 (PDP-4) | Formula: | C59 H82 N18 O15 S2 | Definition date: | 2013-08-21 | Last modified: | 2013-08-21 |
|
![PRD_000942 PRD_000942](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000942.svg) | PRD_000942 | Name: | modified protein phyllopod peptide BI-117C3 | Formula: | C79 H137 N25 O16 S | Definition date: | 2013-08-14 | Last modified: | 2013-08-14 |
|
![PRD_000943 PRD_000943](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000943.svg) | PRD_000943 | Name: | Protein phyllopod | Formula: | C74 H138 N24 O16 S | Definition date: | 2013-08-14 | Last modified: | 2013-08-14 |
|
![PRD_000970 PRD_000970](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000970.svg) | PRD_000970 | Name: | Synthetic peptide LR | Formula: | C43 H72 N13 O13 S | Definition date: | 2013-07-24 | Last modified: | 2013-07-24 |
|
![PRD_001127 PRD_001127](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001127.svg) | PRD_001127 | Name: | GRAMICIDIN A | Formula: | C103 H140 N20 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-10 | Last modified: | 2013-07-10 |
|
![PRD_001128 PRD_001128](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001128.svg) | PRD_001128 | Name: | GRAMICIDIN C | Formula: | C101 H139 N19 O18 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
![PRD_001129 PRD_001129](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001129.svg) | PRD_001129 | Name: | Microcin C7 analog | Formula: | C28 H51 N12 O11 S | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
![PRD_001126 PRD_001126](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001126.svg) | PRD_001126 | Name: | Microcin C7 ANALOG | Formula: | C28 H51 N12 O11 Se | Definition date: | 2013-06-26 | Last modified: | 2013-06-26 |
|
![PRD_001122 PRD_001122](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001122.svg) | PRD_001122 | Name: | CYCLOSPORIN D | Formula: | C64 H115 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
![PRD_001123 PRD_001123](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001123.svg) | PRD_001123 | Name: | CYCLOSPORIN C | Formula: | C64 H114 N10 O14 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
![PRD_001108 PRD_001108](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001108.svg) | PRD_001108 | Name: | CYCLOSPORIN A | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 8 TO BE 4,N-DIMETHYLNORLEUCINE. | Definition date: | 2013-06-19 | Last modified: | 2013-06-19 |
|
![PRD_000925 PRD_000925](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000925.svg) | PRD_000925 | Name: | Caspase inhibitor | Formula: | C42 H58 N6 O12 | Definition date: | 2013-06-12 | Last modified: | 2013-06-12 |
|
![PRD_000995 PRD_000995](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000995.svg) | PRD_000995 | Name: | D-peptide inhibitor DPMI-delta | Formula: | C73 H106 F3 N18 O18 | Definition date: | 2012-12-12 | Last modified: | 2013-06-10 |
|
![PRD_000898 PRD_000898](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000898.svg) | PRD_000898 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | Formula: | C50 H74 N8 O12 | Definition date: | 2013-01-16 | Last modified: | 2013-06-03 |
|
![PRD_000899 PRD_000899](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000899.svg) | PRD_000899 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C53 H67 N7 O11 S | Definition date: | 2013-01-16 | Last modified: | 2013-06-03 |
|
![PRD_000910 PRD_000910](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000910.svg) | PRD_000910 | Name: | B4Z inhibitor | Formula: | C24 H44 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|